Optiver Holding’s Beam Therapeutics BEAM Stock Holding History

Optiver Holding’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.5K	Buy	569 +442	+348%	+$13.3K	﹤0.01%	1529
2026 Q1	$3.03K	Sell	127 -85	-40%	-$2.36K	﹤0.01%	1665
2025 Q4	$5.88K	Sell	212 -415	-66%	-$10.6K	﹤0.01%	1293
2025 Q3	$15.2K	Buy	627 +298	+91%	+$5.93K	﹤0.01%	1067
2025 Q2	$5.6K	Buy	329 +13	+4%	+$226	﹤0.01%	1165
2025 Q1	$6.17K	Buy	+316	New	+$8.28K	﹤0.01%	1038

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Optiver Holding's BEAM Position: Q2 2026 in Review

Optiver Holding increased its Beam Therapeutics (BEAM) stake by 348% in Q2 2026, buying an estimated $13.3K and bringing the position to 569 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Optiver Holding first reported a position in BEAM in Q1 2025 and has held it in 6 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Optiver Holding held 569 shares of Beam Therapeutics worth $19.5K as of Q2 2026.
Optiver Holding bought 442 Beam Therapeutics shares in Q2 2026, an estimated $13.3K.
Beam Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1529 holding.
Optiver Holding first reported a position in Beam Therapeutics in Q1 2025 and has held it in 6 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.